Binding of the pro-inflammatory cytokine interleukin-l (IL-1) in the brain
was first shown a decade ago [1], Interleukin-l receptors (LL-IR) in the br
ain were, at that time, proposed to play a role in mediating symptoms of si
ckness such as fever, activation of the hypothalamo-pituitary adrenal (HPA)
-axis, behavioural depression and increased sleeping. Two years later, IL-1
immunoreactivity was shown in microglia of patients with Alzheimer's disea
se [2]. Subsequent studies provided evidence for IL-1 expression in most ac
ute and chronic CNS pathologies and gave rise to the concept that glial IL-
1 contributes to an inflammatory response in the brain. Recently, new membe
rs of the IL-l receptor family have been discovered and roles for brain IL-
1 other than in inflammation are starting to emerge. During a recent meetin
g* in Biarritz, leading experts in the field reflected on the accomplishmen
ts and prospects in this rapidly expanding area of neurobiology.